News & Events

• December 21, 2017
  

  Qualitative Development and Content Validity of the Non–Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-Reported Outcome Instrument

  McCarrier K, Abraham L, Blum S, Bush E, Bushnell D, Carpenter L, Coons S, Houle C, Martin M, Mathews M, Trivedi M, Thase M, on behalf of the PRO Consortium Depression Working Group. Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure. 53rd New Clinical Drug Evaluation Unit (NCDEU): An Annual Meeting Sponsored by the American Society of Clinical Psychopharmacology (ASCP); 2013 May 28; Hollywood, FL, USA.

• May 18, 2016
  

  PRO Consortium Webinar: Methods for Determining Clinically Meaningful Change

  This webinar explores methodological approaches for determining whether changes observed in patient-reported outcome measures and other clinical outcome assessments are clinically meaningful. Moderator: Stacie Hudgens, MA (Clinical Outcome Solutions) Presenters: Joseph C. Cappelleri, PhD (Pfizer Inc.), Cheryl Coon, PhD (Outcometrix) and Kathy Wyrwich, PhD (Evidera)...
• May 16, 2014
  

  Identifying and Measuring the Core Symptoms Reported by Persons with Asthma: A review of the Existing Qualitative Literature and Patient-Reported Outcome Measures

• May 16, 2014
  

  Development of the Initial Version of the Asthma Daily Symptom Diary

• October 9, 2013
  

  Assessing the translatability of a new patient-reported outcome measure for Major Depressive Disorder